A new reverse genetics system for norovirus could aid in the development of novel antiviral therapies and vaccines.

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

The entire vaccine ecosystem is under threat, prompted less by data than a seeming desire to upend a system that has worked well for the American population for decades.

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price ...

Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...

Researchers hail new trial as ‘important step forward’ in protecting vulnerable populations against fatal virus ...

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025.

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company ...

Bharat Biotech partners with Biofabri to produce the MTBVAC tuberculosis vaccine, ensuring supply for over 70 countries.

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Sanofi agreed to buy vaccine specialist Dynavax Technologies in a $2.2 billion cash deal, turning to dealmaking in a bid to ...

But new research suggests that a vaccine designed to protect you from shingles may have an unexpected hidden perk: It could ...